bioRxiv Science⌕ Search

Biology subjects

Daniels, D. E.

Publications and source records attributed to Daniels, D. E..

2 recordsLinked to original sources

Long dsRNA on the move: Extracellular vesicles deliver dsRNA for antiviral protection in human cells

Viruses make long (>40 bp) double stranded RNA (LdsRNA) during replication, which stimulates the innate antiviral immune response. In vertebrates, LdsRNA can induce the type I interferon response (IFN) or the antiviral RNA interference response (dsRNAi) to limit viral replication. Extracellular vesicles (EVs) have previously been shown to carry a variety of nucleic acids for intercellular signaling, and insects and plants have been shown to package LdsRNA in EVs as part of their antiviral immune response. We hypothesized that a similar phenomenon occurs in vertebrates in which EVs traffic LdsRNA between cells during viral infection to induce an antiviral response in naive cells. In this study we showed that both vesicular stomatitus virus (VSV)-derived and in vitro transcribed (ivt)-LdsRNA can be packaged into EVs. LdsRNA was detectable by immunoblots in EVs extracted by both differential ultracentrifugation from ivt-LdsRNA treated U937 and ExoQuick-TCTM precipitation from VSV-infected U937 cells (dsRNA-EVs) but not uninfected controls (control EVs). Isolated EVs were roughly 100 nm in diameter and were able to protect LdsRNA from degradation by RNase III. LdsRNA delivery by dsRNA-EVs was visualized in HEL-299 cells via immunocytochemistry (ICC). The LdsRNA-EVs protected against infection from HCoV-229E, while control EVs did not. Together these results indicate EVs can package and deliver long dsRNA to provide antiviral protection in naive vertebrate cells. Author SummaryWhen viruses infect cells, they produce double-stranded RNA, a molecule that alerts the body to the presence of infection and triggers antiviral defenses. Previous studies have shown that cells can release small membrane-bound packages called extracellular vesicles, which carry biological messages to other cells. However, it was not known whether antiviral double-stranded RNA could be transported in these vesicles and shared with neighboring cells. In this study, we investigated whether human cells package double-stranded RNA into extracellular vesicles and whether this cargo helps protect other cells from viral infection. We found that both synthetic and virus-derived double-stranded RNA were incorporated into extracellular vesicles and shielded from degradation. These vesicles successfully delivered double-stranded RNA to untreated cells, substantially protecting these cells from infection with a human coronavirus. Our findings suggest that cells can communicate antiviral warnings to neighboring cells by packaging double-stranded RNA into extracellular vesicles. This work reveals a previously unrecognized way that antiviral protection may spread through tissues during infection. By extending antiviral signals beyond directly infected cells, extracellular vesicles may help coordinate a broader host defense response. Understanding this natural communication system could also inform the development of new RNA-based antiviral therapies.

immunology↗

Human cellular model systems of β-thalassemia enablein-depth analysis of disease phenotype

{beta}-thalassemia is a prevalent genetic disorder causing severe anemia due to defective erythropoiesis, with few treatment options. Studying the underlying molecular defects is impeded by paucity of suitable patient material. In this study we created human disease cellular model systems for {beta}-thalassemia, which accurately recapitulate the phenotype of patient erythroid cells. We also developed a high throughput compatible fluorometric-based assay for evaluating severity of disease phenotype and utilised the assay to demonstrate positive response of lines to verified reagents, providing validation for such applications. TMT-based comparative proteomics confirmed the same profile of proteins previously reported, whilst providing new insights into the altered molecular mechanisms in {beta}-thalassemia erythroid cells, with upregulation of a wide range of biological pathways and processes observed. Overall, the lines provide a sustainable supply of disease cells as novel research tools, for identifying new therapeutic targets, and as screening platforms for novel drugs and therapeutic reagents.

cell biology↗